Search

everythinglearnresearchcommunity

for

Search:↓

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

DPCP is effective for treating severe alopecia areata, but relapse is common.

DCP in isopropanol is better tolerated for treating alopecia areata.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

PDCD4 is important for controlling skin cell growth and healing.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

A man developed severe skin reactions after using a treatment for hair loss.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Drug companies were interested in advertising directly to consumers to make back their money, but most didn't think it would help and were concerned about negative effects.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

The JCCP wants new rules for the UK aesthetics industry to improve safety and standards.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Dendrobium candidum polysaccharides promote hair growth.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Online skin care companies offer easy access to treatments but may have ethical issues like confirming patient identity, prescribing unproven therapies, and not fully explaining medication side effects. They should prioritize patient care over profit.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.